Dyslipidemia in Cardiovascular Disease

• Status: Completed
• Trial end date: 2009-11-01

Summary

A multi-center, randomized, double-blinded equivalence clinical trial to evaluate efficacy and safety of LipiLou 20 mg versus Lipitor 20 mg in hypercholesterolemic patients with higher risk cardiovascular disease in Korea.

• Phase: Phase 4

Details

• Lead Sponsor: Chong Kun Dang Pharmaceutical
• Treatments: Atorvastatin; Atorvastatin Calcium